Secretory leukocyte protease inhibitor in punch biopsies from human colonic mucosa
Secretory leukocyte protease inhibitor (SLPI) is a wellknown protease inhibitor. Its function is thought to be protease/protease-inhibitor balance. Free proteolytic activity, mainly pancreatic elastase, anionic trypsin and granulocytic elastase, has been demonstrated in faecal extracts from patients...
Saved in:
Main Authors: | Max Nyström, Ulla Peterson Westin, Carina Linder, Kjell Ohlsson |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2001-01-01
|
Series: | Mediators of Inflammation |
Online Access: | http://dx.doi.org/10.1080/09629350120093740 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
IgE-mediated histamine release from nasal mucosa is inhibited by SLPI (secretory leukocyte protease inhibitor) to the level of spontaneous release
by: U. Westin, et al.
Published: (1998-01-01) -
Production of Secretory Leucocyte Protease Inhibitor (SLPI) in Human Pancreatic β-Cells
by: Max Nyström, et al.
Published: (1999-01-01) -
Secretory Leukocyte Protease Inhibitor Is an Inducible Antimicrobial Peptide Expressed in Staphylococcus aureus Endophthalmitis
by: Victor E. Reviglio, et al.
Published: (2007-01-01) -
The Ability of Secretory Leukocyte Protease Inhibitor to Inhibit Apoptosis in Monocytes Is Independent of Its Antiprotease Activity
by: Niamh McGarry, et al.
Published: (2015-01-01) -
Effects of Pregnancy and Bacterial Vaginosis on Proinflammatory Cytokine and Secretory Leukocyte Protease Inhibitor Concentrations in Vaginal Secretions
by: Jennifer Balkus, et al.
Published: (2010-01-01)